Savant Capital’s Amylyx Pharmaceuticals AMLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-57,565
Closed -$187K 1423
2024
Q3
$187K Sell
57,565
-38,313
-40% -$124K ﹤0.01% 1287
2024
Q2
$182K Buy
+95,878
New +$182K ﹤0.01% 1145